Financial Information

Highlights

Net Sales

Graph：Net Sales

Operating Income

Graph：Operating Income

Ordinary Income

Graph：Ordinary Income

Research and Development Expenditure

Graph：Research and Development Expenditure

Geographical Segment Sales

Graph：Geographical Segment Sales

Sales by Segment

Graph：Sales by Segment

Consolidated Financial Data(JPY million / % change)

  FY2005 FY2006 FY2007 FY2008 FY2009
Net Sales 753,139 853,948 928,480 955,947 1,084,291
10.1% 13.4% 8.7% 3.0% 13.4%
Operating Income 58,849 91,490 118,254 91,520 98,481
4.3% 55.5% 29.3% -22.6% 7.6%
Ordinary Income 70,658 113,983 124,125 96,103 109,057
4.9% 61.3% 8.9% -22.6% 13.5%
Net Income 26,593 52,874 61,865 47,083 67,443
-28.2% 98.8% 17.0% -23.9% 43.2%
Research and Development Expenditure 103,703 105,255 101,804 135,900 151,848
19.6% 1.5% -3.3% 33.5% 11.7%

(JPY million / %)

  FY2005 FY2006 FY2007 FY2008 FY2009
Total Assets 881,134 982,113 1,033,976 1,298,789 1,458,375
Net Assets 392,170 667,781 731,782 863,815 948,456
Equity Capital Ratio 44.50% 45.90% 48.60% 62.30% 64.20%

Consolidated financial figures for FY2005 ― 2007 pertain to Otsuka Pharmaceutical Co., Ltd. and are shown for reference purposes only.

Otsuka Group